Spots Global Cancer Trial Database for Body Composition Analysis in Patients Undergoing Chemoembolization
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Body Composition Analysis in Patients Undergoing Chemoembolization
Official Title: Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.
Study ID: NCT01777698
Conditions
Interventions
Study Description
Brief Summary: Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of patients with hepatocellular carcinoma are associated with cirrhosis. Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into the hepatic tumor where the principal artery is embolized. Bioelectrical impedance bases its evaluation in a model where the body is conformed by two different compartments: fat mass and fat free mass. Bioelectrical impedance is complemented by vectorial analysis, which is independent to the state of hydration and is helpful to monitor any changes in corporal composition. It can be used as a control for the interpretation of the bioelectrical impedance.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico city, , Mexico
Contact Details
Name: Aldo Torre, M.D, M.Sc.
Affiliation: Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
